Estimated antiretroviral therapy coverage among people living with HIV in Ghana
Ghana: Estimated antiretroviral therapy coverage among people living with HIV was 56.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Ghana, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among people living with hiv in Ghana stood at 56.0%. That is the highest value across all 26 years on record.
The figure is up 21.7% on the previous year and up 124.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Ghana peaked at 56.0% in 2025 and was at its lowest, 0.0%, in 2000.
Ghana ranks 115th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Ghana, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 1.0% | +0.0% |
| 2006 | 2.0% | +100.0% |
| 2007 | 4.0% | +100.0% |
| 2008 | 7.0% | +75.0% |
| 2009 | 10.0% | +42.9% |
| 2010 | 13.0% | +30.0% |
| 2011 | 19.0% | +46.2% |
| 2012 | 22.0% | +15.8% |
| 2013 | 24.0% | +9.1% |
| 2014 | 26.0% | +8.3% |
| 2015 | 25.0% | -3.8% |
| 2016 | 28.0% | +12.0% |
| 2017 | 31.0% | +10.7% |
| 2018 | 32.0% | +3.2% |
| 2019 | 33.0% | +3.1% |
| 2020 | 36.0% | +9.1% |
| 2021 | 39.0% | +8.3% |
| 2022 | 44.0% | +12.8% |
| 2023 | 45.0% | +2.3% |
| 2024 | 46.0% | +2.2% |
| 2025 | 56.0% | +21.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.5% | 0.0% | 10.0% | 10 |
| 2010s | 25.3% | 13.0% | 33.0% | 10 |
| 2020s | 44.3% | 36.0% | 56.0% | 6 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.5623 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.06 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5816 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Ghana?
- Estimated antiretroviral therapy coverage among people living with hiv in Ghana was 56.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Ghana?
- The highest recorded value was 56.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Ghana?
- The lowest recorded value was 0.0% in 2000.
- How does Ghana rank for estimated antiretroviral therapy coverage among people living with hiv?
- Ghana ranks 115th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Ghana?
- Over the last ten years it is up 124.0%. The long-run trend across the full record is volatile.
- Where does this Ghana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).